The complement cascade in kidney disease: From sideline to center stage

American Journal of Kidney Diseases

Volumn 62, Issue 3, 2013, Pages 604-614

  McCaughan, Jennifer A ^a,b   O'Rourke, Declan M ^b   Courtney, Aisling E ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Complement activation; complement dysregulation; kidney disease

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN; MEMBRANE COFACTOR PROTEIN;

ANTIBODY MEDIATED REJECTION; ARTICLE; CELLS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; RECEPTOR BLOCKING; REPERFUSION INJURY;

COMPLEMENT ACTIVATION; COMPLEMENT DYSREGULATION; KIDNEY DISEASE;

ADULT; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; KIDNEY DISEASES;

EID: 84883243180     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.12.033     Document Type: Article

References (99)

1. P. Ehrlich, J. Morgenroth Zur Theorie der Lysenwirkung Berlin Klin Wchsr 36 1899 6
2. C. Ehrnthaller, A. Ignatius, F. Gebhard, M. Huber-Lang New insights of an old defense system: structure, function, and clinical relevance of the complement system Mol Med 17 3-4 2011 317 329
3. M.M. Markiewski, J.D. Lambris The role of complement in inflammatory diseases from behind the scenes into the spotlight Am J Pathol 171 3 2007 715 727
4. S.P. Berger, M.R. Daha Complement in glomerular injury Semin Immunopathol 29 4 2007 375 384
5. US Dept of Health and Human Services, US Food and Drug Administration FDA approves Soliris for rare pediatric blood disorder September 23, 2011 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm272990.htm Accessed July 30, 2012
6. M.J. Walport Complement First of two parts N Engl J Med 344 14 2001 1058 1066
7. J.S. Navratil, S.C. Watkins, J.J. Wisnieski, J.M. Ahearn The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells J Immunol 166 5 2001 3231 3239
8. R.J. Smith, J. Alexander, P.N. Barlow New approaches to the treatment of dense deposit disease J Am Soc Nephrol 18 9 2007 2447 2456
9. G.B. Appel, H.T. Cook, G. Hageman Membranoproliferative glomerulonephritis type II (dense deposit disease): an update J Am Soc Nephrol 16 5 2005 1392 1403
10. K.A. Kurtz, A.J. Schlueter Management of membranoproliferative glomerulonephritis type II with plasmapheresis J Clin Apher 17 3 2002 135 137
11. R.J. Smith, C.L. Harris, M.C. Pickering Dense deposit disease Mol Immunol 48 14 2011 1604 1610
12. W. Vogt, B. Damerau, B. Lühmann, D. Hesse, Y. Haller Complement activation in human lymph: modulation by the contact activation system and by leukocytes Int Arch Allergy Appl Immunol 79 4 1986 423 433
13. M. Huber-Lang, J.V. Sarma, F.S. Zetoune Generation of C5a in the absence of C3: a new complement activation pathway Nat Med 12 6 2006 682 687
14. J.Q. He, C. Wiesmann, M. van Lookeren Campagne A role of macrophage complement receptor CRIg in immune clearance and inflammation Mol Immunol 45 16 2008 4041 4047
15. R.P. Rother, S.A. Rollins, C.F. Mojcik, R.A. Brodsky, L. Bell Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria Nat Biotechnol 25 11 2007 1256 1264
16. D.M. Lee, D.S. Friend, M.F. Gurish, C. Benoist, D. Mathis, M.B. Brenner Mast cells: a cellular link between autoantibodies and inflammatory arthritis Science 297 5587 2002 1689 1692
17. Z.M. Liu, S.M. Zhu, X.J. Qin Silencing of C5a receptor gene with siRNA for protection from gram-negative bacterial lipopolysaccharide-induced vascular permeability Mol Immunol 47 6 2010 1325 1333
18. T.M. Carlos, J.M. Harlan Leukocyte-endothelial adhesion molecules Blood 84 7 1994 2068 2101
19. R. Habib, M.C. Gubler, C. Loirat, H.B. Maiz, M. Levy Dense deposit disease: a variant of membranoproliferative glomerulonephritis Kidney Int 7 4 1975 204 215
20. M.C. Pickering, M.J. Walport Links between complement abnormalities and systemic lupus erythematosus Rheumatology (Oxford) 39 2 2000 133 141
21. M.C. Pickering, M. Botto, P.R. Taylor, P.J. Lachmann, M.J. Walport Systemic lupus erythematosus, complement deficiency, and apoptosis Adv Immunol 76 2000 227 324
22. A.J. Nauta, L.A. Trouw, M.R. Daha Direct binding of C1q to apoptotic cells and cell blebs induces complement activation Eur J Immunol 32 6 2002 1726 1736
23. M. Botto, M.J. Walport C1q, autoimmunity and apoptosis Immunobiology 205 4-5 2002 395 406
24. M.A. Seelen, L.A. Trouw, M.R. Daha Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus Curr Opin Nephrol Hypertens 12 6 2003 619 624
25. G. Moroni, M. Trendelenburg, N. Del Papa Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis Am J Kidney Dis 37 3 2001 490 498
26. Y. Kusunoki, Y. Akutsu, N. Itami Urinary excretion of terminal complement complexes in glomerular disease Nephron 59 1 1991 27 32
27. G. Biesecker, S. Katz, D. Koffler Renal localization of the membrane attack complex in systemic lupus erythematosus in nephritis J Exp Med 154 6 1981 1779 1794
28. Y. Wang, Q. Hu, J.A. Madri, S.A. Rollins, A. Chodera, L.A. Matis Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5 Proc Natl Acad Sci U S A 93 16 1996 8563 8568
29. L.H. Beck Jr, R.G. Bonegio, G. Lambeau M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy N Engl J Med 361 1 2009 11 12
30. M. Nangaku, S.J. Shankland, W.G. Couser Cellular response to injury in membranous nephropathy J Am Soc Nephrol 16 5 2005 1195 1204
31. P.J. Baker, R.F. Ochi, M. Schulze, R.J. Johnson, C. Campbell, W.G. Couser Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats Am J Pathol 135 1 1989 185 194
32. D. Kerjaschki, M. Schulze, S. Binder Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy J Immunol 143 2 1989 546 552
33. T.J. Neale, R. Ullrich, P. Ojha, H. Poczewski, A.J. Verhoeven, D. Kerjaschki Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis Proc Natl Acad Sci U S A 90 8 1993 3645 3649
34. T. Takano, A.V. Cybulsky Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells: role of cyclooxygenase-1 and -2 Am J Pathol 156 6 2000 2091 2101
35. S.J. Shankland, J. Pippin, R.H. Pichler Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy Kidney Int 50 1 1996 116 124
36. M. Schiffer, M. Bitzer, I.S. Roberts Apoptosis in podocytes induced by TGF-beta and Smad7 J Clin Invest 108 6 2001 807 816
37. P. Mundel, S.J. Shankland Podocyte biology and response to injury J Am Soc Nephrol 13 12 2002 3005 3015
38. A. Petermann, J. Pippin, K. Hiromura Mitotic cell cycle proteins increase in podocyte despite lack of proliferation Kidney Int 63 1 2003 113 122
39. J. Reiser, J. Oh, I. Shirato Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin J Biol Chem 279 33 2004 34827 34832
40. S. Sethi, C.M. Nester, R.J. Smith Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion Kidney Int 81 5 2012 434 441
41. F. Fakhouri, V. Fremeaux-Bacchi, L.H. Noel, H.T. Cook, M.C. Pickering C3 glomerulopathy: a new classification Nat Rev Nephrol 6 8 2010 494 499
42. S. Sethi, F.C. Fervenza Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification Semin Nephrol 31 4 2011 341 348
43. B. Alchi, D. Jayne Membranoproliferative glomerulonephritis Pediatr Nephrol 25 8 2010 1409 1418
44. L. Nakopoulou Membranoproliferative glomerulonephritis Nephrol Dial Transplant 16 6 2001 71 73
45. M. Endo, H. Ohi, I. Ohsawa, T. Fujita, M. Matsushita, T. Fujita Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy Nephrol Dial Transplant 13 8 1998 1984 1990
46. B.D. Oortwijn, A. Roos, L. Royle Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy J Am Soc Nephrol 17 12 2006 3529 3539
47. H. Suzuki, K. Kiryluk, J. Novak The pathophysiology of IgA nephropathy J Am Soc Nephrol 22 10 2011 1795 1803
48. K.N. Lai Pathogenesis of IgA nephropathy Nat Rev Nephrol 8 5 2012 275 283
49. M. Matsuda, K. Shikata, J. Wada Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy Nephron 80 4 1998 408 413
50. A. Roos, M.P. Rastaldi, N. Calvaresi Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease J Am Soc Nephrol 17 6 2006 1724 1734
51. A. Roos, L.H. Bouwman, D.J. van Gijlswijk-Janssen, M.C. Faber-Krol, G.L. Stahl, M.R. Daha Human IgA activates the complement system via the mannan-binding lectin pathway J Immunol 167 5 2001 2861 2868
52. P. Sanchez-Corral, M. Melgosa Advances in understanding the aetiology of atypical haemolytic uraemic syndrome Br J Haematol 150 5 2010 529 542
53. M. Jozsi, P.F. Zipfel Factor H family proteins and human diseases Trends Immunol 29 8 2008 380 387
54. A. Richards, M.R. Buddles, R.L. Donne Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition Am J Hum Genet 68 2 2001 485 490
55. M. Jozsi, S. Heinen, A. Hartmann Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions J Am Soc Nephrol 17 1 2006 170 177
56. D. Kavanagh, T. Goodship Genetics and complement in atypical HUS Pediatr Nephrol 25 12 2010 2431 2442
57. J. Caprioli, M. Noris, S. Brioschi Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood 108 4 2006 1267 1279
58. T.S. Jokiranta, Z.Z. Cheng, H. Seeberger Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site Am J Pathol 167 4 2005 1173 1181
59. P.D. Walker Dense deposit disease: new insights Curr Opin Nephrol Hypertens 16 3 2007 204 212
60. R. Martinez-Barricarte, M. Heurich, F. Valdes-Canedo Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation J Clin Invest 120 10 2010 3702 3712
61. C.D. West, A.J. McAdams Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase Am J Kidney Dis 32 1 1998 56 63
62. M. Kosieradzki, J. Kuczynska, J. Piwowarska Prognostic significance of free radicals: mediated injury occurring in the kidney donor Transplantation 75 8 2003 1221 1227
63. J.M. Thurman, M.S. Lucia, D. Ljubanovic Acute tubular necrosis is characterized by activation of the alternative pathway of complement Kidney Int 67 2 2005 524 530
64. M.D. Parker, P.A. Chambers, J.P. Lodge, J.R. Pratt Ischemia-reperfusion injury and its influence on the epigenetic modification of the donor kidney genome Transplantation 86 12 2008 1818 1823
65. J. Damman, W.N. Nijboer, T.A. Schuurs Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation Nephrol Dial Transplant 26 7 2011 2345 2354
66. J. Damman, T.A. Schuurs, R.J. Ploeg, M.A. Seelen Complement and renal transplantation: from donor to recipient Transplantation 85 7 2008 923 927
67. H.K. Eltzschig, T. Eckle Ischemia and reperfusion - from mechanism to translation Nat Med 17 11 2011 1391 1401
68. M. Zhang, E.M. Alicot, I. Chiu Identification of the target self-antigens in reperfusion injury J Exp Med 203 1 2006 141 152
69. L.K. Kayler, L. Kiss, V. Sharma Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d Transplantation 85 6 2008 813 820
70. L.C. Racusen, P.F. Halloran, K. Solez Banff 2003 meeting report: new diagnostic insights and standards Am J Transplant 4 10 2004 1562 1566
71. M. Haas C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival Clin Nephrol 75 4 2011 271 278
72. S.V. Brodsky, G.M. Nadasdy, R. Pelletier Expression of the decay-accelerating factor (CD55) in renal transplants - a possible prediction marker of allograft survival Transplantation 88 4 2009 457 464
73. + T cells Immunity 28 3 2008 425 435
74. Q. Li, Q. Peng, G. Xing Deficiency of C5aR prolongs renal allograft survival J Am Soc Nephrol 21 8 2010 1344 1353
75. G. Castellano, A.M. Woltman, N. Schlagwein Immune modulation of human dendritic cells by complement Eur J Immunol 37 10 2007 2803 2811
76. T. Lin, W. Zhou, C.A. Farrar, R.E. Hargreaves, N.S. Sheerin, S.H. Sacks Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection Am J Pathol 168 4 2006 1241 1248
77. P. Hillmen, N.S. Young, J. Schubert The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria N Engl J Med 355 12 2006 1233 1243
78. P. Hillmen, C. Hall, J.C. Marsh Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria N Engl J Med 350 6 2004 552 559
79. Goodship T, Muus P, Legendre C, et al. Eculizumab-an effective treatment for patients with atypical hemolytic syndrome (aHUS) receiving plasma exchange/infusion. Abstract presented at Renal Association Conference 2011; June 6-9, 2011; Birmingham, England.
80. Sheerin N, Legendre C, Babu S, et al. Eculizumab is effective in patients with atypical haemolytic syndrome (aHUS) resistant to plasma exchange/infusion. Abstract presented at Renal Association Conference 2011; June 6-9, 2011; Birmingham, England.
81. A. Hill, P. Hillmen, S.J. Richards Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria Blood 106 7 2005 2559 2565
82. R.A. Brodsky, N.S. Young, E. Antonioli Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria Blood 111 4 2008 1840 1847
83. A.S. Bomback, R.J. Smith, G.R. Barile Eculizumab for dense deposit disease and C3 glomerulonephritis Clin J Am Soc Nephrol 7 5 2012 748 756
84. J.A. McCaughan, D.M. O'Rourke, A.E. Courtney Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies Am J Transplant 12 4 2012 1046 1051
85. A.R. Biglarnia, B. Nilsson, T. Nilsson Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation Transpl Int 24 8 2011 e61 e66
86. J.E. Locke, C.M. Magro, A.L. Singer The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection Am J Transplant 9 1 2009 231 235
87. S. Chandran, L. Baxter-Lowe, J.L. Olson, S.J. Tomlanovich, A. Webber Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation - a case report Transplant Proc 43 5 2011 2097 2101
88. M.D. Stegall, T. Diwan, S. Raghavaiah Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients Am J Transplant 11 11 2011 2405 2413
89. F. Gueler, S. Rong, W. Gwinner Complement 5a receptor inhibition improves renal allograft survival J Am Soc Nephrol 19 12 2008 2302 2312
90. A.G. Lewis, G. Köhl, Q. Ma, P. Devarajan, J. Köhl Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival Clin Exp Immunol 153 1 2008 117 126
91. T.V. Arumugam, I.A. Shiels, A.J. Strachan, G. Abbenante, D.P. Fairlie, S.M. Taylor A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats Kidney Int 63 1 2003 134 142
92. X. Zheng, X. Zhang, B. Feng Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury Am J Pathol 173 4 2008 973 980
93. X. Tillou, N. Poirier, S. Le Bas-Bernardet Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons Kidney Int 78 2 2010 152 159
94. G. Castellano, R. Melchiorre, A. Loverre Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion- induced renal damage Am J Pathol 176 4 2010 1648 1659
95. M.J. Walport Complement Second of two parts N Engl J Med 344 15 2001 1140 1144
96. H. Patel, R.A. Smith, S.H. Sacks, W. Zhou Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage J Am Soc Nephrol 17 4 2006 1102 1111
97. J.R. Pratt, M.J. Hibbs, A.J. Laver, R.A. Smith, S.H. Sacks Allograft immune response with sCR1 intervention Transpl Immunol 4 1 1996 72 75
98. Medical Research Council MRC News and Publications: Vision revealed for extending the life of an organ transplant; September 2010 http://www.mrc.ac.uk/ Newspublications/News/MRC007225 Accessed May 30, 2012
99. K. Hadaya, S. Ferrari-Lacraz, D. Fumeaux Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation Am J Transplant 11 11 2011 2523 2527